Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History STIM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics STIM

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Neuronetics Inc

STIM
Current price
3.40 USD -0.02 USD (-0.58%)
Last closed 3.42 USD
ISIN US64131A1051
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 223 789 024 USD
Yield for 12 month +89.94 %
1Y
3Y
5Y
10Y
15Y
STIM
21.11.2021 - 28.11.2021

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Address: 3222 Phoenixville Pike, Malvern, PA, United States, 19355

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.83 USD

P/E Ratio

Dividend Yield

Financials STIM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures STIM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+74 890 000 USD

Last Year

+71 348 000 USD

Current Quarter

+31 975 000 USD

Last Quarter

+22 493 000 USD

Current Year

+54 161 000 USD

Last Year

+51 705 000 USD

Current Quarter

+15 738 000 USD

Last Quarter

+14 893 000 USD
EBITDA -35 784 000 USD
Operating Margin TTM -34.45 %
Price to Earnings
Return On Assets TTM -19.39 %
PEG Ratio
Return On Equity TTM -144.50 %
Wall Street Target Price 6.83 USD
Revenue TTM 89 448 000 USD
Book Value 0.54 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 83.60 %
Dividend Yield
Gross Profit TTM 57 411 000 USD
Earnings per share -1.32 USD
Diluted Eps TTM -1.32 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -54.23 %

Stock Valuation STIM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 3.21
Price Sales TTM 2.50
Enterprise Value EBITDA -2.02
Price Book MRQ 6.34

Technical Indicators STIM

For 52 Weeks

0.52 USD 5.92 USD
50 Day MA 3.97 USD
Shares Short Prior Month 2 730 278
200 Day MA 2.75 USD
Short Ratio 5.27
Shares Short 3 114 623
Short Percent 8.41 %